Doximity, Inc.

Doximity, Inc.

DOCS
Doximity, Inc.US flagNew York Stock Exchange
57.36
USD
+0.32
(+0.56%)
1.11EPS
51.68P/E
10.77BMarket Cap
Aug 06Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Jeffrey A. Tangney
Full Time Employees
827
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500, 3rd Street San Francisco CA United States of America 94107
IPO Date
Jun 24, 2021
Similar Companies
Business
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Company News

  • Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS?

  • DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?

  • Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

  • OGN or DOCS: Which Is the Better Value Stock Right Now?

  • Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

  • DOCS Boosts Client Retention via Workflow Integration and AI Tools

  • Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

  • Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

  • Doximity Declines 4.4% in a Month: How to Play the Stock Now?

  • Dr Martens surges 23% as investors lace up for recovery story

  • Dr Martens marketing 'reset' saw annual revenue and profit retreat, eyes return to growth this year

  • The “English Warren Buffett” Dumped Most of His Portfolio, But Bought Big Into These 3 Stocks

  • Doximity Rides on Telehealth Demand: Will This Drive Sales Further?

  • Which Telehealth Stock Should You Be Targeting?

  • Dr Martens interims a first test for new CEO after shares stumble to all-time low

  • Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

  • Doximity to Present at the William Blair 45th Annual Growth Stock Conference

  • Doximity: A Closer Look at Its Investment Potential

  • Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

  • Doximity: Strong Growth but What's Next?